Glow blend reconstitution protocol

This protocol describes the reconstitution and storage of the lyophilized Glow blend in standard research workflows. Glow combines three compounds commonly studied together for skin, hair, and connective-tissue regenerative-research models: GHK-Cu, BPC-157, and TB-500. Values below reflect published handling literature for each component; study design is the responsibility of the qualified investigator.

At a glance

Parameter	Value
Recommended diluent	Bacteriostatic Water (USP, 0.9% benzyl alcohol)
Recommended volume (60 mg combined: 50 mg GHK-Cu + 5 mg BPC-157 + 5 mg TB-500)	3.0 mL
Final concentration	GHK-Cu: 16.7 mg/mL · BPC-157: 1.7 mg/mL · TB-500: 1.7 mg/mL
Stability — lyophilized	≥24 months at -20 °C, sealed, light-protected
Stability — reconstituted	30 days at 2–8 °C, light-protected (GHK-Cu color sensitivity)
Solution appearance	Clear with distinctive deep blue tint from GHK-Cu coordination

Procedure

1. Equilibrate the vial to room temperature.
2. Sterile prep: wipe stopper with isopropyl. Use sterile syringe and needle.
3. Inject diluent slowly along the inner wall. The lyophilized cake has a pale blue-violet tint from the GHK-Cu component.
4. Swirl gently. Do not shake — agitation can promote oxidation of GHK-Cu's copper coordination.
5. Verify: solution should be clear with a characteristic blue color from GHK-Cu coordination. Faded blue suggests copper dissociation; do not use.

Why these three compounds are blended

The combination is structured around regenerative-research pathways with partial overlap:

• GHK-Cu — copper tripeptide; effects on extracellular matrix remodeling, collagen synthesis, hair follicle stem cells, anti-inflammatory gene expression.
• BPC-157 — angiogenesis, nitric-oxide signaling, fibroblast migration. Most relevant here for vascular and tissue-repair contributions.
• TB-500 (Thymosin Beta-4) — actin regulation, cell migration into repair sites, anti-fibrotic activity.

For research models targeting skin appearance, hair regrowth, or dermal repair, the combination is intended to engage matrix remodeling (GHK-Cu), vascular support (BPC-157), and cellular migration (TB-500) in a single administration. The doses reflect published research ranges for each individual component; review the component-specific articles in this library for additional context.

Compound notes

Two handling considerations specific to the blend:

• The copper signature must be preserved. If the blue color fades during storage or you observe precipitation, GHK-Cu's copper coordination has been compromised. The other two compounds may still be intact, but the blend has degraded as a complete product.
• Avoid metals and chelators in any dilution buffer. EDTA and strong reducing agents (DTT, β-mercaptoethanol) strip copper from GHK-Cu. Use standard physiological buffers (PBS, saline, cell media) for downstream dilutions.

Storage

Reconstituted blend is stable for approximately 30 days at 2–8 °C, light-protected. For longer storage, aliquot into sterile single-use tubes and freeze at -20 °C or colder. Lyophilized stability is ≥24 months at -20 °C light-protected.

Notes

This protocol describes reconstitution parameters from published handling literature for each component. It is not a recommendation for any specific research protocol or design. For research use only. Not for human or veterinary use.

References

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Compound in the Light of the New Gene Data. Int J Mol Sci 2018;19:1987. PMID: 29986520
2. Chang CH, Tsai WC, Lin MS, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol 2011;110:774–780. PMID: 21030672
3. Sosne G, Qiu P, Christopherson PL, Wheater MK. Thymosin beta 4 suppression of corneal NFkappaB. Exp Eye Res 2007;84:663–669. PMID: 17320071